Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Recurrence and XRCC1[original query] |
|---|
| Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head & neck 2005 Mar 27 (3): 232-42. Geisler Stacy A, Olshan Andrew F, Cai Jianwen, Weissler Mark, Smith Joanna, Bell Dougl |
| Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Aug 24 (23): 3789-98. Wu Xifeng, Gu Jian, Wu Tsung-Teh, Swisher Stephen G, Liao Zhongxin, Correa Arlene M, Liu Jun, Etzel Carol J, Amos Christopher I, Huang Maosheng, Chiang Silvia S, Milas Luke, Hittelman Walter N, Ajani Jaffer |
| Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenetics and genomics 2007 Jul 17 (7): 529-38. Jaremko Malgorzata, Justenhoven Christina, Schroth Werner, Abraham Benny K, Fritz Peter, Vollmert Caren, Illig Thomas, Simon Wolfgang, Schwab Matthias, Brauch Hiltr |
| Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta oncologica (Stockholm, Sweden) 2007 46 (1): 31-41. Sanyal Somali, De Verdier Petra J, Steineck Gunnar, Larsson Per, Onelöv Erik, Hemminki Kari, Kumar Raj |
| Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Nov 13 (22 Pt 1): 6632-8. Huang Shu-Pin, Huang Chao-Yuan, Wang Jyh-Seng, Liu Chia-Chu, Pu Yeong-Shiau, Yu Hong-Jeng, Yu Chia-Cheng, Wu Tony T, Huang Chun-Hsiung, Wu Wen-Jeng, Chou Yii-Her, Wu Ming-Tsa |
| XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer biology & therapy 2008 May 7 (5): 645-50. Mittal Rama Devi, Singh Ranjana, Manchanda Parmeet Kaur, Ahirwar Dinesh, Gangwar Ruchika, Kesarwani Pravin, Mandhani An |
| Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. British journal of cancer 2009 May 100 (10): 1680-6. Chang-Claude J, Ambrosone C B, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl M-L, Wenz F, Schmezer P, Popanda |
| Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer biology & therapy 2010 Jul 10 (1): 13-8. Gao Rui, Price Douglas K, Dahut William L, Reed Eddie, Figg William |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy]. Zhonghua yi xue za zhi 2011 Jan 91 (4): 256-9. Liu Yong-ping, Ling Yang, Zhang Ya-ping, Liu Bao-r |
| Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival. Journal of hepatology 2012 Sep 57 (3): 621-7. Jung Seok Won, Park Neung Hwa, Shin Jung Woo, Park Bo Ryung, Kim Chang Jae, Lee Jong-Eun, Shin Eun-Soon, Kim Jeong A, Chung Young-H |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin. International journal of clinical and experimental medicine 2015 8 (7): 11167-73. Li Pengchao, Zhang Xiaolei, Deng Xiaheng, Tao Jun, Qin Chao, Yang Xiao, Cheng Yidong, Lu Qiang, Wang Zengjun, Yin Changj |
| Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder. Oncology reports 2015 Oct 34 (4): 1667-74. Chantre-Justino Mariana, Alves Gilda, Britto Constança, Cardoso Angélica, Scherrer Luciano, Dos Santos Moreira Aline, Quirino Raul, Ornellas Antonio, Leitão Alvaro, Lage Claud |
| XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun 36 (6): 4591-6. Deng Xiaheng, Zhang Xiaolei, Cheng Yidong, Yang Xiao, Zhao Ruizhe, Liu Xuzhong, Li Xiao, Qin Chao, Lu Qiang, Yin Changj |
| Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma. Oncology letters 2017 Feb 13 (2): 704-714. Huang Xue, Liu Changmin, Cui Yayun, Zhang Heping, Liu Yongping, Zhou Xifa, Luo Judo |
| Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer. International journal of environmental research and public health 2018 Jul 15 (8): . Carta Angela, Pavanello Sofia, Mastrangelo Giuseppe, Fedeli Ugo, Arici Cecilia, Porru Stefa |
| Effect of Arg399Gln single-nucleotide polymorphism in XRCC1 gene on survival rate of Indian squamous cell head-and-neck cancer patients. Journal of cancer research and therapeutics 0 16 (3): 551-558. Dutta Debnarayan, Abarna Rajadurai, Shubham Mehatre, Subbiah Kannan, Duraisamy Sriprakash, Chinnusamy Rayappa, Anbalagan Moort |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated With Concomitant Chemoradiation. British journal of biomedical science 2022 79 10120. Abbas Mohammad, Kushwaha Vandana Singh, Srivastava Kirti, Banerjee Monis |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Frontiers in oncology 2022 12 928605. He Kewen, Zhang Shaotong, Pang Jiaohui, Yin Jiani C, Mu Dianbin, Wang Jun, Ge Hong, Ma Jie, Yang Zhe, Zheng Xiaoli, Dong Lihua, Zhang Junli, Chang Pengyu, Li Li, Tang Shanshan, Bao Hua, Wu Xue, Wang Xiaonan, Shao Yang, Yu Jinming, Yuan Shuang |
| Noninvasive circulating tumor cell and urine cellular XPC (rs2228001, A2815C) and XRCC1 (rs25487, G1196A) polymorphism detection as an effective screening panel for genitourinary system cancers. Translational cancer research 2022 2 8 (8): 2803-2812. Wu Cen, Xu Cheng, Wang Guaxiu, Zhang Dahu, Zhao Xiao |
| The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer. Journal of cancer research and therapeutics 2023 10 19 (5): 1248-1254. Mustafa Karaa?aç, Ça?layan Geredeli, Mahmut Selman Y?ld?r?m, Tamer Alt?nok, ?sa Dede, Ali ?nal, Ay?e Gül Zamani, Bu?ra Kaya, Ahmet Demirkaz?k, Mehmet Art |
| Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia. Clinica chimica acta; international journal of clinical chemistry 2024 4 117899. Amin Zhang, Wancheng Liu, Xiaodong Guo, Hexiao Jia, Yihong Wei, Can Can, Na He, Chunyan Ji, Daoxin |
- Page last reviewed:Feb 1, 2024
- Content source: